Acquati F, Rönicke V, Taramelli R, Müller H J
Department of Molecular Biology, Boehringer Mannheim, Germany.
Clin Genet. 1997 Nov;52(5):303-7. doi: 10.1111/j.1399-0004.1997.tb04347.x.
We have previously described four DNaseI hypersensitive sites (DH 1 to DH4) in the 40-kb intergenic region between the plasminogen gene and the apo(a) gene. Here, we wanted to analyse whether any of these sites, located 4, 21, 28 and 34 kb upstream of the apo(a) transcriptional start site, would act as an enhancer on a minimal apo(a) promoter. Starting from a cloned, highly expressed apo(a) allele, we obtained four fragments comprising the DHI to DH4 sites, respectively. These fragments were cloned in both orientations into a luciferase reporter gene plasmid comprising a minimal apo(a) promoter (-100 to +141 with respect to the transcriptional start site). Our results from transfection studies with the resulting series of reporter gene plasmids into liver (HepG2) and non-liver (HeLa) cells suggest that the four DH sites from the selected apo(a) allele do not provide a strong, liver-specific enhancer activity.
我们之前曾描述过纤溶酶原基因与载脂蛋白(a)基因之间40 kb基因间区域中的四个脱氧核糖核酸酶I超敏位点(DH1至DH4)。在此,我们想要分析位于载脂蛋白(a)转录起始位点上游4、21、28和34 kb处的这些位点是否会作为最小载脂蛋白(a)启动子上的增强子发挥作用。从一个克隆的、高表达的载脂蛋白(a)等位基因开始,我们分别获得了包含DHI至DH4位点的四个片段。这些片段以两种方向克隆到一个包含最小载脂蛋白(a)启动子(相对于转录起始位点为-100至+141)的荧光素酶报告基因质粒中。我们将所得一系列报告基因质粒转染至肝脏(HepG2)和非肝脏(HeLa)细胞的研究结果表明,所选载脂蛋白(a)等位基因的四个DH位点并未提供强大的、肝脏特异性的增强子活性。